Exiris makes use of several platform technologies for target identification and validation. In addition, Exiris is developing its own antibody and drug conjugate technologies: Cancer stem cell platform, Drug conjugate technology and Antibody ID technology.

read more


Exiris provides contract research services and collaborative development agreements using its innovative technology platforms: CSC Platform, Target ID, Drug-Conjugate platform, Custom human mAb production, Biomarker discovery and (…)

read more

Job opportunities

Despite no open positions are currently available, feel free to apply here: Exiris will save your CV in a database that will be consulted when in search of new experienced and highly motivated collaborators.


read more

Contact us

Exiris srl

Via Castel Romano 100
00128 Roma RM – Italy

Legal address:
Viale Carlo Felice 103
00185 Rome – Italy

+39 06 50576530